Patent · US Active

Cereblon modulators and uses thereof

US10869860B2 · kind B2 · utility

1Cited by

0References

30Claims

0Family size

Assignees

Vividion Therapeutics, Inc. · US
THE SCRIPPS RESEARCH INSTITUTE · US

Inventors

Benjamin F. Cravatt · San Diego, US
Matthew Patricelli · San Diego, US
Dean Stamos · Carlsbad, US
Gabe SIMON · San Diego, US
Benjamin HORNING · San Diego, US
David Weinstein · Dobbs Ferry, US
Ekaterina VINOGRADOVA · San Antonio, US

Key dates

Filing date	Jul 3, 2019
Grant date	Dec 22, 2020
Priority date	—
Expiry date	Jul 3, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D451/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for modulating cereblon neosubstrates. A small molecule modulator of Formula (I*), or a pharmaceutically acceptable salt or solvate thereof can be used to modulate cereblon neosubstrates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.